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TRPV1 regulates excitatory innervation of OLM
neurons in the hippocampus
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TRPV1 is an ion channel activated by heat and pungent agents including capsaicin, and has
been extensively studied in nociception of sensory neurons. However, the location and
function of TRPV1 in the hippocampus is debated. We found that TRPV1 is expressed in
oriens-lacunosum-moleculare (OLM) interneurons in the hippocampus, and promotes
excitatory innervation. TRPV1 knockout mice have reduced glutamatergic innervation of OLM
neurons. When activated by capsaicin, TRPV1 recruits more glutamatergic, but not
GABAergic, terminals to OLM neurons in vitro. When TRPV1 is blocked, glutamatergic input
to OLM neurons is dramatically reduced. Heterologous expression of TRPV1 also increases
excitatory innervation. Moreover, TRPV1 knockouts have reduced Schaffer collateral LTP,
which is rescued by activating OLM neurons with nicotine—via a2b2-containing nicotinic
receptors—to bypass innervation defects. Our results reveal a synaptogenic function of
TRPV1 in a speciﬁc interneuron population in the hippocampus, where it is important for
gating hippocampal plasticity.
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T
he transient receptor potential vanilloid 1 (TRPV1)
channel is a non-selective cation channel activated by
heat, acidic conditions and naturally occurring exogenous
molecules including capsaicin, the pungent ingredient in chilli
peppers1–6. TRPV1 was ﬁrst discovered and characterized in
the peripheral nervous system, where it plays a prominent role in
nociception1.
The presence of TRPV1 in the brain, and especially in the
hippocampus, has been debated for many years. TRPV1 was
initially reported to be absent in the brain1. Later studies, however,
reported broad expression of TRPV1 in the brain including the
hippocampus7–9, where it was observed in cell bodies of pyramidal
neurons throughout the CA1 and CA3 regions and the dentate
gyrus of the hippocampal formation9. However, more recent
studies have challenged the notion that TRPV1 is broadly expressed
in the hippocampus. Only a small population of cells in the
hippocampus was found to express TRPV1 in a reporter mouse
line in which lacZ expression is driven by the TRPV1 promoter10.
The few TRPV1-positive cells in the hippocampus co-expressed
reelin, and were hypothesized to correspond to Cajal–Retzius
cells, which die during development, and TRPV1 was not detected
in the adult hippocampus by RT–PCR10.
However, TRPV1 has been implicated in synaptic plasticity in
the hippocampus since the observation that TRPV1 knockouts
have decreased long-term potentiation (LTP) of synaptic strength
in the Schaffer collateral pathway compared to wild type (WT)11.
Addition of exogenous capsaicin to hippocampal slices also has
been reported to increase LTP12,13, further suggesting that
functional TRPV1 is present in the adult hippocampus, and
that TRPV1, if activated by endogenous ligands, may affect LTP.
Subsequent studies resulted in disparate ﬁndings regarding the
role of TRPV1 in hippocampal synaptic plasticity. One model
proposed that high-frequency stimulation of the Schaffer
collateral pathway activates presynaptic TRPV1 on pyramidal
neurons, which persistently reduces glutamate release onto
interneurons14. Thus TRPV1 knockouts would have higher
inhibition and a subsequent reduction in Schaffer collateral
LTP. By contrast, in the perforant pathway it was proposed that
high-frequency stimulation activates post-synaptic TRPV1 on
pyramidal neurons, which induces endocytosis of AMPA
receptors, and would result in an increase in LTP in TRPV1
knockouts15. However, TRPV1 was not localized in these studies,
and these models are both at odds with reports of restricted
expression of TRPV1 in the adult hippocampus10. Thus, both the
presence of TRPV1 in the hippocampus—whether broadly
expressed, sparsely expressed, or not at all—and how TRPV1
affects hippocampal plasticity and function, is still unclear.
Most previous studies describing a function of TRPV1 in
synaptic plasticity have localized TRPV1 to excitatory neurons7,9,14,
which comprise the principle cells of the glutamatergic tri-synaptic
circuit in the hippocampus. However, TRPV1 has also recently
been reported at post-synaptic sites in inhibitory neurons16.
Although inhibitory interneurons represent only B10% of the
neurons in the hippocampus, it has recently become clear that
diverse populations of inhibitory interneurons—where at least 21
different types have been described in the CA1 region alone17—are
key players in the control of principal cells in the hippocampus to
modulate synaptic plasticity18.
Here we discovered, using TRPV1 knockouts to validate
quantitative PCR (qPCR) primers and TRPV1 antibodies, that
TRPV1 is expressed in oriens-lacunosum-moleculare (OLM)
(oriens-lacunosum-moleculare) interneurons in the hippocampus.
TRPV1-expressing OLM neurons have profuse excitatory innerva-
tion, which is signiﬁcantly reduced in TRPV1 knockouts. Upon
stimulation with capsaicin, excitatory input to these OLM neurons
was increased, and this effect was blocked by a TRPV1-speciﬁc
antagonist and abolished in TRPV1 knockouts. Moreover,
heterologous expression of TRPV1 in neurons that do not normally
express it, increased excitatory, but not inhibitory, input to these
neurons.
We further found that the reduced Schaffer collateral
LTP observed in hippocampal slices from TRPV1 knockouts is
caused by the decrease in excitatory innervation of OLM cells:
LTP in TRPV1 knockouts was rescued by speciﬁcally activating
OLM neurons with nicotine—via the a2 receptor—to bypass
innervation defects. Together our data show speciﬁc expression
of TRPV1 within a sub-population of hippocampal neurons and
reveal a novel function of TRPV1 channels in the hippocampus in
regulating excitatory innervation, which explains previously
reported deﬁcits in synaptic plasticity observed in TRPV1
knockouts.
Results
TRPV1 is expressed in the hippocampus. To test if TRPV1 is
present in the hippocampus, we ﬁrst examined TRPV1 mRNA
levels in adult WT and TRPV1 knockout animals by qPCR.
We used dorsal root ganglia (DRG) as a positive control for
detection of TRPV1, since DRG are reported to have high levels
of TRPV1 expression19,20. As expected, the sequence that is
deleted in the TRPV1 knockout mouse corresponding to exon 13
and encoding the putative TRPV1 pore region (TRPV1 PR), was
present in WT DRG but absent in TRPV1 knockouts (Fig. 1a).
Importantly, TRPV1 mRNA in WT mice was also detected in the
hippocampus, albeit at much lower levels than in DRG.
In addition to the sequence encoding the pore region, we
also used primers to detect N- and C-terminal sequences of
TRPV1–which have been used to generate many commercially
available TRPV1-speciﬁc antibodies–and the VR.50 sv splice
isoform as a positive control, which has been reported to be
present at higher levels in hippocampus than in DRG21. We
found all three sequences present in the hippocampus of WT
mice, where VR.50 sv levels were higher in hippocampus than in
DRG, as expected. Surprisingly, however, mRNA sequences
corresponding to the TRPV1 N-terminus, C-terminus and the
VR.50 sv splice isoform of TRPV1 remained in the TRPV1
knockouts, in both DRG and hippocampus (Fig. 1b).
To determine if the TRPV1 channel is expressed in brain and
hippocampus at the protein level, we performed western blots
using an N-terminus-speciﬁc TRPV1 antibody in whole brain and
hippocampal homogenates. A band of B90 kDa, corresponding
to TRPV1, was detected in WT homogenates of whole brain and
hippocampus, and was absent in TRPV1 knockouts (Fig. 1c). The
C-terminal antibodies that we tested by western blot, did not yield
a clear band of the correct size (Supplementary Fig. 1).
To further test if functional TRPV1 is present in the
hippocampus, we examined calcium responses of hippocampal
neurons to capsaicin, which speciﬁcally activates the TRPV1
channel. TRPV1 is permeable to cations including Ca2þ 1.
Monitoring Ca2þ inﬂux upon TRPV1 activation therefore allows
us to determine if TRPV1 is expressed in hippocampal neurons as
an active, functional channel. We performed time-lapse imaging
of Fluo-4-loaded hippocampal neurons during 40Hz ﬁeld
stimulation (as a positive control of calcium inﬂux in response
to depolarization) followed by 1 mM capsaicin stimulation.
A small number of hippocampal neurons in vitro that responded
to ﬁeld stimulation also responded to capsaicin treatment
(Fig. 1d). This response remained in the presence of TTX and
CNQX, but was blocked by the TRPV1 antagonist SB-366791
(Supplementary Fig. 2). In addition, TRPV1 knockout neurons
did not respond to capsaicin, indicating that the capsaicin
response in WT neurons occurs via the TRPV1 channel. None of
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the neurons analysed responded to application of the vehicle
dimethylsulphoxide (DMSO) used as a negative control.
Although the peak of the ﬂuorescence signal corresponding to
Ca2þ inﬂux during electrical stimulation and capsaicin treatment
was variable among different neurons, the magnitude of the
capsaicin response was usuallyB50% of that evoked by electrical
stimulation. The decay of Ca2þ signal in response to capsaicin
was also more gradual than in response to ﬁeld stimulation,
and in some cases the capsaicin-mediated Ca2þ response did not
decay completely to baseline before termination of recording
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(Fig. 1d). These results reveal that the TRPV1 channel is indeed
expressed in the hippocampus and these channels are expressed
in a functional state, in a small sub-population of neurons.
TRPV1 expression in a sub-population of hippocampal neurons.
To investigate the identity of the potential sub-population of
hippocampal neurons that express TRPV1, we immunostained
dissociated hippocampal neurons and hippocampal sections
with TRPV1 antibodies. In WT mouse hippocampal cultures
immunostained with an N-terminal TRPV1 antibody, we found
a small population of neurons with positive TRPV1 signal
(Fig. 1e,f). These TRPV1-positive cells detected with the N-terminal
antibody were absent in TRPV1 knockout cultures. When we
used a C-terminal TRPV1 antibody, we identiﬁed the same
small population of neurons detected by the N-terminal TRPV1
antibody. However, the C-terminal antibody still detected these
neurons in TRPV1 knockout hippocampal cultures, although the
intensity of signal was signiﬁcantly reduced in TRPV1 knockout
neurons (Fig. 1e,f). In combination with the qPCR data above, this
suggests that the TRPV1 C-terminus persists in the TRPV1
knockouts. This sequence may correspond to a protein product
generated by aberrant splicing in the TRPV1 knockouts, or to a
remaining sequence of a naturally occurring splice isoform, such as
VR.50 sv. The VR.50 sv splice isoform is more prevalent in the
hippocampus than in DRG21, and is also recognized by the
C-terminal TRPV1 antibody, but not by the N-terminal TRPV1
antibody (Supplementary Fig. 3A). Because TRPV1 is homologous
to TRPV2, TRPV3 and TRPV4, we also tested if the TRPV1
C-terminal antibody recognizes these additional TRPV isoforms.
We found TRPV2 and TRPV4 signal in sub-populations of
dissociated hippocampal neurons, but these neurons were distinct
from those positive for TRPV1 recognized by the TRPV1
C-terminal antibody (Supplementary Fig. 3B,C). Interestingly,
however, we found high co-localization of TRPV1 and TRPV3 in
a subset of cells. The TRPV3 antibody did not recognize TRPV1 in
over-expressing cells (Supplementary Fig. 3D), verifying that the
TRPV3 antibody is isoform-speciﬁc and TRPV1 and TRPV3 are
indeed co-expressed in a subset of hippocampal neurons. TRPV1
and TRPV3 knockouts have a similar reduction in Schaffer
collateral LTP that is rescued by blocking GABAergic inhibition22.
In addition TRPV1 and TRPV3 proteins interact, and their
co-expression enhances TRPV1 responses to capsaicin23. Thus it is
possible that these two isoforms cooperate in the same subset of
inhibitory interneurons to affect LTP.
Immunohistochemistry of adult mouse hippocampal sections
using the TRPV1 N-terminal and C-terminal antibodies yielded
similar results. The N-terminal TRPV1 antibody identiﬁed a
restricted sub-population of neurons expressing TRPV1, and such
neurons were mainly present in the stratum oriens (Fig. 1g and
Supplementary Fig. 3E). These TRPV1-expressing neurons were
largely absent in TRPV1 knockouts (reduced by 80%). Similar to
the observations made in vitro, the C-terminal TRPV1 antibody
recognized the same small sub-population of TRPV1-expressing
neurons in the stratum oriens of WT mice, but still recognized
some cells in hippocampal sections of TRPV1 knockouts, where
the number of cells per slice in TRPV1 knockouts was reduced by
40% compared to WT (Fig. 1h). The distribution of TRPV1-
expressing neurons in the stratum oriens was reminiscent of
somatostatin-expressing OLM (oriens-lacunosum-moleculare)
neurons, which are known to be present in this region24. These
neurons have large somata with axons extending to the stratum
lacunosum moleculare25,26, and horizontal dendrites projecting
through the stratum oriens as well as to further layers of the CA1
region27. Indeed, we found that most TRPV1-expressing neurons
in the stratum oriens also expressed somatostatin (Fig. 1i),
suggesting that they are OLM cells.
TRPV1 is expressed in oriens-lacunosum-moleculare neurons.
Using a lacZ reporter mouse, TRPV1 was previously reported to be
expressed in the hippocampus in a very small population of reelin-
expressing presumed Cajal–Retzius cells10, which largely die before
adulthood. However, reelin is also expressed in inhibitory
interneurons in the hippocampus, and was recently found in a
sub-population of somatostatin-positive OLM neurons28. We
immunostained hippocampal sections with the N-terminal
TRPV1 antibody, somatostatin and reelin and found that indeed,
these markers co-localized in a sub-population of presumptive
OLM cells in the stratum oriens (Fig. 2a,c). To further test the idea
that TRPV1 is expressed in OLM neurons we immunostained for
metabotropic glutamate receptor 7 (mGluR7), which is present in
presynaptic terminals innervating OLM neurons29,30. We found
that 81% of TRPV1-expressing neurons in the stratum oriens are
densely decorated by detectable mGluR7 signal (Fig. 2b,c),
indicating that these neurons correspond to OLM neurons in the
hippocampus. Most TRPV1-positive neurons were also positive for
the inhibitory interneuron marker GAD65, as expected (Fig. 2c),
and for the C-terminal TRPV1 antibody, which recognizes the
VR.50 sv splice isoform that remains in the TRPV1 knockouts
(Figs 1e,g,h and 2c). Only 20% of TRPV1-expressing cells were
positive for parvalbumin in stratum oriens of PV-Tomato reporter
mice, consistent with reports that a small subset of OLM neurons
are parvalbumin-positive28,31. We did not detect any VIP-positive
TRPV1-expressing neurons in sections from VIP-Tomato reporter
mice (Fig. 2b,c).
Figure 1 | Expression of TRPV1 in the hippocampus. (a) qPCR showing relative mRNA expression levels of the TRPV1 pore region in DRG (D) and
hippocampus (H), normalized to WT DRG levels. (b) qPCR showing relative mRNA expression levels of the TRPV1 N-T, C-Tand pore regions (PR), and of the
VR.50sv splice isoform in DRG (left) and hippocampus (right) normalized to WT (n¼ 3 repetitions; error¼ s.e.m., signiﬁcance determined by unpaired
Student’s t-test with Welch’s correction; *Po0.05, **Po0.01, ***Po0.001, ****Po0.0001). (c) Western blot conﬁrming that the N-terminal TRPV1 antibody
recognizes TRPV1 in WT but not in TRPV1 KO homogenates from whole brain (upper) and hippocampus (lower). Tubulin served as a loading control; n¼ 3
repetitions. (d) Images of Fluo-4-based Ca2þ responses in dissociated WTand TRPV1 knockout hippocampal cultures before, during and after ﬁeld stimulation
and after capsaicin addition (left); scale bar, 20mm. Right panels show representative (coloured) and average (black) traces of Fluo-4 signal. Red arrows
indicate AWTneuron that responded to 1mM capsaicin treatment; no response was observed in TRPV1 KO cultures (n¼ 18 time-lapse recordings; 3 cultures)
or to DMSO, used as a negative control (n¼ 16 recordings; three cultures). (e) The N-terminal TRPV1 antibody detects a subset of WT hippocampal neurons
positive for TRPV1, and signal is absent in TRPV1 KO neurons (n¼6; two cultures). The C-terminal TRPV1 antibody detects the same sub-population of WT
hippocampal neurons, but signal remains in TRPV1 KOs; scale bar, 20mm. (f) Quantitation of N-terminal and C-terminal TRPV1 antibody signal in WT and
TRPV1 KO hippocampal neurons (n¼ 12; 4 cultures; error¼ s.e.m., signiﬁcance determined by unpaired Student’s t-test with Welch’s correction **Po0.01,
***Po0.001). (g) Immunostain of TRPV1 and DAPI showing TRPV1-positive cells in the stratum oriens in WT hippocampal sections, compared to TRPV1 KOs;
scale bar, 20mm. (h) Quantiﬁcation of number of neurons positive for N-terminal or C-terminal TRPV1 antibody signal in WT and TRPV1 KO hippocampal
sections (n¼ 5 sections each; error¼ s.e.m., signiﬁcance determined by unpaired Student’s t-test with Welch’s correction *Po0.01, **Po0.01, ***Po0.001).
(i) Immunostain of TRPV1, somatostatin (SOM) and DAPI in WT and TRPV1 KO hippocampal sections; scale bar, 100mm.
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We tested additional markers in hippocampal cultures, in
which individual positive cells are more readily identiﬁed and the
co-localization of markers can be easily quantiﬁed. We ﬁrst tested
if, in culture, TRPV1-expressing cells also co-express reelin and
somatostatin; this was indeed the case, since B87% of TRPV1-
expressing cells were also positive for reelin, and 62% were
positive for somatostatin (Fig. 3a,c). Because reelin is an
important signalling molecule necessary for the proper formation
of cortical and hippocampal laminae during development32, we
tested if TRPV1 knockouts had any alterations in gross
hippocampal (and cortical) architecture. In coronal brain
sections from age-matched adult WT and TRPV1 knockout
mice immunostained with the neuronal marker Neurotrace, and
DAPI, to mark cell nuclei, we failed to detect any obvious
structural alteration in the brain of TRPV1 knockout mice;
cortical layers I–VI, DG and CA subdivisions of the
hippocampus, and subcortical structures including the ventral
posteromedial and posterolateral nuclei are present and well-
deﬁned (Supplementary Fig. 4).
We further conﬁrmed that TRPV1-expressing neurons are
inhibitory interneurons (and not Cajal–Retzius cells, as previously
postulated10); 96% of TRPV1-expressing cells were positive for
the inhibitory neuron marker GAD65. Only 14%, and none of
TRPV1-expressing cells, respectively, were positive for
parvalbumin, and VIP (Fig. 3a,c). 80% of TRPV1-expressing
neurons in vitro had mGluR7 in terminals contacting them
(Fig. 3b,c), further indicating that TRPV1 is speciﬁcally expressed
in hippocampal OLM neurons29,30. The majority of TRPV1-
positive neurons were also positive for the C-terminal TRPV1
antibody, which recognizes the VR.50 sv splice isoform that
remains in the TRPV1 knockouts (Figs 1e,f and 3c). There were
more non-TRPV1-expressing reelin, GAD65 and VIP neurons in
dissociated cultures than in the stratum oriens region of
hippocampal sections, most likely representing cells from other
hippocampal regions.
In the peripheral nervous system, nerve growth factor (NGF)
upregulates TRPV1 expression in nociceptors33,34. NGF is also
retrogradely trafﬁcked to septal cholinergic neurons—which
innervate OLM cells35 and promotes their survival36. We
therefore also examined possible co-localization of TRPV1 with
NGF. We found that TRPV1-expressing OLM neurons indeed
express higher levels of NGF compared to surrounding neurons
(Fig. 3d). Furthermore, treatment of hippocampal neurons with
1ngml 1 NGF for 21–24 h increased TRPV1 expression, assayed
both by immunostaining for TRPV1 (Fig. 3e) and by western blot
of TRPV1, synaptobrevin-2 (as a negative control) and tubulin,
used as a load control, in three biological replicates (Fig. 3f). This
suggests that, as in the peripheral nervous system, NGF also
upregulates TRPV1 in the hippocampus.
Interestingly, we found that TRPV1-expressing neurons are
more highly innervated by excitatory vGluT1-positive synaptic
boutons both in vivo (Fig. 3g) and in vitro (Fig. 3h), compared to
surrounding neurons.
TRPV1 promotes excitatory innervation of OLM neurons.
Although TRPV1 has not been reported as a synaptogenic factor,
the high excitatory innervation of TRPV1-expressing OLM
neurons in the hippocampus led us to hypothesize that TRPV1
itself may promote excitatory innervation. To test this, we ﬁrst
evaluated if, in vitro, weak and strong pharmacological activation
of TRPV1 by 21–24 h incubation with either 50 nM or 1 mM
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TRPV1-expressing neuron in the stratum oriens; scale bar¼ 20mm. (h) Immunostain of a dissociated hippocampal neuron culture with TRPV1, vGluT1 and
MAP2 (to mark neuronal cell bodies and processes), showing high vGluT1 innervation of a TRPV1-expressing neuron; scale bar, 20mm.
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capsaicin, or with the TRPV1 antagonist SB-366791, would have
any inﬂuence on innervation of TRPV1-expressing cells. Using
immunocytochemistry we quantiﬁed the number of vGluT1- and
vGAT-positive excitatory and inhibitory terminals, respectively,
contacting TRPV1-expressing neurons compared to surrounding
neurons. We also quantiﬁed the ﬂuorescence intensity of both
markers, and the concomitant signal from an antibody against
the lumenal domain of synaptotagmin1, which was taken up
by recycling synaptic vesicles during depolarization and live
labelling, before ﬁxation (syt1u). The intensity of syt1u signal at
vGluT1 or vGAT-positive terminals acts as a readout of excitatory
and inhibitory presynaptic strength.
On average, TRPV1-expressing neurons had more than twice
the number of excitatory contacts compared to surrounding
neurons (Fig. 4a–c and Supplementary Fig. 5). The number of
excitatory contacts increased after 21–24 h 50 nM capsaicin
treatment, and increased further with a higher concentration of
1 mM capsaicin (Fig. 4c). Interestingly, 1 mM capsaicin also
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doubled the number of vGluT1 puncta on surrounding neurons,
and this effect was absent in TRPV1 knockouts; larger ﬁeld
images including both TRPV1-expressing and non-expressing
neurons following capsaicin treatment are shown in Suppleme-
ntary Fig. 5A. Treatment with 50 nM or 1 mM capsaicin for
only 4 h did not further increase excitatory innervation in
TRPV1-expressing on non-expressing neurons (Supplementary
Fig. 5B,C). VGluT1 puncta intensity and syt1 uptake signal
was also higher in TRPV1-expressing neurons compared to
surrounding neurons, but did not change signiﬁcantly following
capsaicin treatment (Fig. 4d,e), except for syt1 ﬂuorescence
intensity following 1mM capsaicin treatment, which decreased
slightly in both TRPV1-expressing and non-expressing neurons
(Fig. 4e). Treatment of cultures with a selective TRPV1
antagonist, SB-366791 (1 mM) decreased excitatory synapse
number only on TRPV1-expressing neurons, and reverted the
effect of capsaicin treatment (Fig. 4a–c). In addition, the same
sub-population of OLM neurons in TRPV1 knockout cultures
(identiﬁed by C-terminal TRPV1 antibody signal, which remains
in the knockouts) had decreased excitatory innervation compared
to WT TRPV1-expressing neurons, and capsaicin had no effect
on excitatory synapse number on TRPV1 knockout neurons
(Fig. 4b,c).
Inhibitory innervation of TRPV1-expressing hippocampal
neurons was similar to the surrounding neurons (Fig. 4f–h; note
that the scale of graphs in Fig. 4c–e,h–j is the same for
comparison) and was unchanged by 1 mM capsaicin treatment,
blockade of TRPV1 channels with SB-366791, or knockout of
TRPV1 (Fig. 4h). The intensity of vGAT and syt1 uptake signal in
inhibitory terminals contacting TRPV1-expressing cells was also
similar to that of surrounding neurons, and unchanged by
capsaicin, SB-366791 treatment or knockout of TRPV1 (Fig. 4i,j).
We further used the TRPV1 knockout model to examine the
effects of TRPV1 on excitatory and inhibitory synapse number in
OLM interneurons identiﬁed by co-expression of somatostatin
and reelin. WT OLM neurons co-expressing somatostatin and
reelin had more than twice as many vGluT1 synapses as
surrounding neurons (Fig. 5a,b), and the number of synapses
increased two-fold following 1mM capsaicin treatment. The
number of excitatory terminals on TRPV1 knockout OLM
neurons, by contrast, was reduced compared to WT; there was
no signiﬁcant difference in the number of excitatory synapses on
OLM neurons versus surrounding neurons in TRPV1 knockout
cultures. In addition, the capsaicin-induced increase in excitatory
innervation of OLM neurons in WT cultures, was absent in
TRPV1 knockout cultures (Fig. 5b; larger ﬁeld images of WT
and TRPV1 knockout neurons including TRPV1-expressing and
non-expressing surrounding neurons following capsaicin
treatment are shown in Supplementary Fig. 5D). By contrast,
knockout of TRPV1 did not signiﬁcantly affect the number of
inhibitory synapses on OLM interneurons, and 1 mM capsaicin
also had no effect on inhibitory synapse number on OLM
neurons in WT (or knockout) cultures (Fig. 5c,d). Thus, TRPV1
appears to speciﬁcally promote excitatory, and not inhibitory,
innervation of OLM neurons.
To verify this ﬁnding electrophysiologically, we recorded from
putative OLM neurons—identiﬁed as neurons with large somata
located in the stratum oriens—in hippocampal slices from WT
and TRPV1 knockout mice. Because OLM neurons represent the
vast majority of inhibitory interneurons in the stratum oriens of
hippocampal slices37,38, we identiﬁed cells in this region by
morphology for whole-cell patch clamp experiments. We found
that mEPSC frequency was signiﬁcantly reduced in putative OLM
neurons in TRPV1 knockout hippocampal slices compared to
those in WT slices (Fig. 6a,b), while mEPSC amplitude was
unchanged (Fig. 6c). To conﬁrm that these neurons expressed
TRPV1, we then recorded currents following perfusion of 1 mM
capsaicin. In WT slices, 9 out of 12 recorded neurons responded
to capsaicin with inward currents ranging from 100 to 400 pA
(Fig. 6d). In TRPV1 knockout slices out of 19 recorded neurons,
we observed no signiﬁcant inward currents in response to
capsaicin perfusion, except for one cell with a 400 pA depolarizing
response, and another with a 200 pA hyperpolarizing response,
which were identiﬁed as outliers by ROUT analysis of current
peak amplitude. These data conﬁrm our ﬁndings that TRPV1
promotes excitatory innervation of OLM neurons.
Heterologous TRPV1 expression increases excitatory inputs.
We next sought to determine if TRPV1 can promote excitatory
synapse formation in cells that do not normally express it. To test
this, we transfected rat hippocampal neurons at DIV2 with
TRPV1-IRES-GFP (or EGFP as a control) using Lipofectamine
2000, and assayed synapse number and presynaptic strength on
transfected neurons at DIV12–13. The transfection efﬁciency
achieved using this technique is relatively low, with B1–5%
of cells transfected. Thus virtually all presynaptic terminals
contacting transfected neurons are ‘wild-type’, where TRPV1
is only overexpressed post-synaptically. Transfection of
TRPV1-IRES-GFP increased the number of excitatory terminals
contacting transfected neurons compared to EGFP controls
(Fig. 7a,b) (but to a lesser extent than TRPV1-expressing OLM
neurons compared to surrounding neurons). In addition the
ﬂuorescence intensity of vGluT1 in presynaptic terminals (Fig. 7c)
Figure 4 | Post-synaptic TRPV1 promotes excitatory innervation. (a) Quadruple immunocytochemistry images of hippocampal neurons immunostained
for TRPV1, vGluT1, syt1 lumenal antibody internalized by recycling synaptic vesicles during depolarization, and MAP2, in the indicated conditions; scale bar,
20mm. (b) Higher magniﬁcation images of vGluT1 and MAP2 on TRPV1-expressing neurons in hippocampal cultures; scale bar, 5mm. (c) Quantiﬁcation of
excitatory synapse number on TRPV1-positive hippocampal neurons normalized to surrounding cells in the indicated conditions. Black asterisks indicate
signiﬁcance between TRPV1-expressing and surrounding neurons in each condition. Blue asterisks indicate signiﬁcance relative to control for either TRPV1-
expressing cells or surrounding cells. (d) Quantitation of vGluT1, and syt1 uptake (e) intensity in presynaptic terminals contacting TRPV1-expressing
neurons, normalized to surrounding neurons, in the indicated conditions. Images used for quantitation were: WTcontrol n¼ 24, WT 50nM cap. n¼ 12, WT
1mM cap. n¼9, WT 1mM cap. þ 1mM SB n¼ 12, WT 1mM SB n¼ 12, TRPV1 KO control n¼ 9, TRPV1 KO 1mM cap. n¼ 9; from ﬁve different cultures.
(f) Immunostains of TRPV1, vGAT, lumenal syt1 antibody internalized by recycling synaptic vesicles during depolarization, and MAP2 in the indicated
conditions; scale bars, 20mm. (g) Higher magniﬁcation images of vGATand MAP2 immunostaining; scale bars, 5 mm. (h) Quantitation of inhibitory synapse
number (number of vGAT-positive puncta) on TRPV1-expressing neurons normalized to surrounding cells. (i) Quantitation of vGAT intensity in presynaptic
terminals contacting TRPV1-expressing neurons, normalized to surrounding neurons, in the indicated conditions. (j) Quantitation of syt1 uptake in
depolarizing conditions in vGAT-positive terminals contacting TRPV1-expressing neurons, normalized to surrounding neurons, in the indicated conditions.
Images used for quantitation were: WT control n¼ 23, WT 50nM cap. n¼ 11, WT 1mM cap. n¼ 9, WT 1mM cap.þ 1mM SB n¼ 12, WT 1mM SB n¼ 12,
TRPV1 KO control n¼9, TRPV1 KO 1mM cap. n¼ 9; from 5 cultures. Error¼ s.e.m., signiﬁcance determined by one-way ANOVA with Tukey’s post hoc test
for multiple comparisons, *Po0.05, **Po0.01, ***Po0.001, ****Po0.0001; ﬂuorescence intensity and synapse number for all conditions was normalized
to the corresponding average value for surrounding neurons in WT cell cultures.
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and the co-localizing syt1 uptake immunoﬂuorescence signal
(Fig. 7d) were also increased on TRPV1-expressing neurons
compared to controls. Blockade of the TRPV1 channel with 1mM
SB-366791 on DIV4 reverted these effects to control levels. We also
measured mEPSC frequency and amplitude electrophysiologically,
and found that mEPSC frequency (which is thought to reﬂect
synapse number or release probability), but not mEPSC amplitude,
was higher in TRPV1-transfected neurons than in EGFP-trans-
fected control neurons (Fig. 7e).
We also tested inhibitory synapse formation and strength on
neurons over-expressing TRPV1 in cultured hippocampal
neurons. Although we found no change in inhibitory synapse
number on TRPV1-IRES-GFP-expressing neurons (Fig. 7f,g),
vGAT ﬂuorescence intensity on these neurons was slightly
decreased compared to EGFP controls, and was unchanged
by blockade of the TRPV1 channel (Fig. 7h). Syt1 antibody
uptake signal at vGAT synapses was also signiﬁcantly reduced
compared to control, and this reduction was absent in the
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Figure 5 | TRPV1 promotes excitatory innervation of OLM neurons. (a) Quadruple immunostains of WT and TRPV1 KO hippocampal neurons with
vGluT1 to assay excitatory presynaptic innervation, somatostatin and reelin to identify OLM cells, and MAP2 to identify neuronal somas and dendritic
processes, in the indicated conditions. Merge indicates combination of vGluT, reelin and MAP-2 channels; scale bar, 20 mm. (b) Quantitation of excitatory
synapse (vGluT1 puncta) number, in the indicated conditions, normalized to surrounding non-TRPV1-expressing cells. TRPV1 KO OLM neurons have
reduced excitatory innervation, compared to WT (n¼ 20 images for all conditions from three cultures). (c) Quadruple immunostain of WTand TRPV1 KO
hippocampal neurons for vGAT, to mark inhibitory synapses, reelin, somatostatin, and MAP2. Merge indicates combination of vGAT, reelin and MAP2
channels; scale bar, 20mm. (d) Quantitation of inhibitory synapse (vGAT puncta) number, in the indicated conditions, normalized to surrounding
non-TRPV1-expressing cells (n¼ 20 images for all conditions from 2 cultures). Error¼ s.e.m., statistical signiﬁcance determined by one-way ANOVA with
Tukey’s post hoc test for multiple comparisons, *Po0.05, **Po0.01, ***Po0.001, ****Po0.0001.
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presence of 1 mM SB-366791 added at DIV4 to block TRPV1
channels (Fig. 7i). The frequency and amplitude of mIPSCs
recorded from TRPV1-transfected neurons were unchanged
compared to EGFP-transfected control neurons, corroborating
the unchanged number of inhibitory terminals innervating
TRPV1-transfected neurons compared to EGFP-transfected
control neurons (Fig. 7j). These results demonstrate that
TRPV1—expressed in cells in which it is normally absent—
promotes excitatory, but not inhibitory, innervation of these cells.
TRPV1-induced innervation requires Ca2þ , NGF and
BDNF. What are the molecular and cellular mechanisms by
which TRPV1 promotes excitatory synapse formation? NGF
increases TRPV1 expression in hippocampal neurons (Fig. 3e,f),
and the high levels of NGF in OLM neurons may therefore
promote TRPV1 expression speciﬁcally in these cells. Activated
TRPV1 increases calcium entry in the cells in which it is
expressed, which may lead to increased activity of these cells,
increased coincident pre- and post-synaptic ﬁring and subsequent
strengthening of existing connections via a Hebbian mechan-
ism39. Increased activity in TRPV1-expressing neurons may then
activate other activity-dependent signalling molecules that
promote excitatory synapse formation. Brain-derived
neurotrophic factor (BDNF), for example, has been reported to
be upregulated by TRPV1 in DRG neurons in response to
inﬂammation40, and activation of TRPV1 increases BDNF
release41. BDNF stimulates synaptogenesis in hippocampal
neurons42, and increases excitatory, but not inhibitory,
presynaptic strength43 and therefore may be important for
TRPV1-mediated excitatory innervation. Indeed, we found that
TRPV1-expressing neurons had increased BDNF levels compared
to non-TRPV1-expressing neurons (Fig. 8a,b). In addition,
WT OLM neurons had a greater number and intensity of
BDNF puncta than TRPV1 knockouts (Fig. 8c,d).
To test if NGF, BDNF or Ca2þ entry through TRPV1
channels are necessary for the increase in excitatory synaptic
innervation mediated by TRPV1, we blocked Ca2þ entry
(by addition of 2mM EGTA), NGF (with bath application of
1 mgml 1 TrkA-Fc), or BDNF (with bath application of
0.4 mgml 1 TrkB-Fc) during incubation with 1mM capsaicin
for 21–24 h, which when applied alone normally induces a
signiﬁcant increase in excitatory innervation, speciﬁcally in
TRPV1-expressing neurons. Interestingly, we found that all of
these treatments blocked the TRPV1-mediated synaptogenic
effect (Fig. 8e,f). Capsaicin plus TrkA-Fc, or capsaicin plus
TrkB-Fc, both reduced capsaicin-induced TRPV1-mediated
excitatory innervation to control levels. Addition of 2mM EGTA
signiﬁcantly reduced excitatory innervation below control
levels, both in the presence and absence of 1 mM capsaicin,
suggesting that calcium inﬂux is necessary for the maintenance of
synapses in general, and not just for synapse formation induced
by TRPV1. Together, these results suggest a pathway whereby
NGF upregulates TRPV1 in OLM neurons, which in turn
increases calcium inﬂux via activated TRPV1. This activates
BDNF, which promotes excitatory innervation of these cells. In
support of this pathway, we found that overexpression of TRPV1
does not upregulate NGF (Fig. 8g) but does upregulate BDNF
(Fig. 8h), in transfected neurons.
We further tested if increasing neuronal activity alone is
sufﬁcient to induce excitatory synapse formation on OLM
neurons. To increase neuronal activity, we transduced hippo-
campal cultures with ChR2-EYFP AAV, or EGFP AAV as a
control, and then delivered pulses of blue light via light-emitting
diode (LED) in the incubator for 24 h. Although LED stimulation
was sufﬁcient to depolarize ChR2-EYFP expressing neurons
(Supplementary Fig. 6A), we did not observe an increase
in excitatory innervation of TRPV1-expressing hippocampal
neurons that were transduced with ChR2-EYFP, compared to
EGFP controls (Supplementary Fig. 6B,C). However, in these
experiments the majority of cells were transduced and the entire
culture was stimulated at low light intensity. It is therefore
still possible that speciﬁc differential levels of activity between
cells may promote excitatory innervation in a Hebbian manner.
TRPV1-induced OLM neuron innervation is necessary for LTP.
The deﬁcient excitatory innervation of OLM neurons in
TRPV1 knockouts that we discovered may explain why TRPV1
knockouts have decreased Schaffer collateral hippocampal
LTP compared to WT mice11. OLM cells directly inhibit the
temporoammonic pathway at distal dendrites of CA1 pyramidal
cells, and disinhibit the Schaffer collateral pathway via contact
with other intermediate inhibitory interneurons (Fig. 9a)35. Less
excitatory innervation of OLM cells would therefore lead to
decreased disinhibition (ie, more inhibition of CA1 pyramidal
neurons) and reduced LTP. To test this idea, we ﬁrst compared
LTP in the Schaffer collateral pathway of acute hippocampal
slices from TRPV1 knockout and WT mice (Fig. 9b). We found a
signiﬁcant decrease in LTP in the Schaffer collateral pathway in
recordings from TRPV1 knockouts compared to WT (Fig. 9c),
suggesting that TRPV1 plays a role in normal hippocampal
functioning and plasticity, as previously reported11,14,15,22.
Nicotine is known to promote the induction of LTP in
the Schaffer collateral pathway44,45. Recently it was reported
that in the hippocampus, OLM neurons exclusively express
the a2 nicotinic receptor subunit, and nicotine-dependent LTP
induction in the Schaffer collateral pathway is mediated
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speciﬁcally through an OLM-dependent disinhibitory
mechanism35. We reasoned that if TRPV1 knockouts have
reduced LTP speciﬁcally due to reduced glutamatergic
innervation of OLM neurons, the LTP deﬁcit in TRPV1
knockouts should be rescued by activating OLM neurons with
nicotine, bypassing the TRPV1-mediated excitatory innervation
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(j) TRPV1-IRES-GFP-expressing neurons have no change in mIPSC frequency or amplitude, compared to control EGFP-expressing neurons (cells used for
analysis: EGFP n¼ 27, TRPV1-IRES-GFP n¼ 24). Error¼ s.e.m.; signiﬁcance determined by unpaired Student’s t-test *Po0.05, **Po0.01, ***Po0.001.
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Figure 8 | TRPV1-induced excitatory synaptogenesis requires calcium inﬂux, NGF and BDNF. (a) Immunostain of rat hippocampal cultures with TRPV1
and BDNF. (b) Quantitation of BDNF signal in somas of TRPV1-expressing neurons normalized to surrounding non-TRPV1-expressing cells (n¼ 15 images from
three cultures; error¼ s.e.m., signiﬁcance determined by unpaired Student’s t-test with Welch’s correction, **Po0.01). (c) Immunostain of WT and TRPV1
knockout mouse cultures with the C-terminal TRPV1 antibody (which detects a remainins splice isoform in the TRPV1 knockouts and marks TRPV1-expressing
cells—Fig. 1e,f), BDNF, and DAPI. (d) Quantitation of BDNF puncta/mm (left panel) and BDNF puncta intensity (right panel) on OLM neurons marked by the
C-terminal TRPV1 antibody, in WT and TRPV1 knockout cultures, normalized to WT. (e) Immunostains of TRPV1, vGluT and MAP2 in cultures in control
conditions, and in cultures treated with capsaicin in the presence of absence of 2mM EGTA to block calcium inﬂux, 1mgml 1 TrkA-Fc to scavenge NGF, or
0.4mgml 1 TrkB-Fc to scavenge BDNF. (f) Quantitation of excitatory synapse number (vGluT puncta number) on TRPV1-expressing hippocampal neurons in
the indicated conditions. Images used for quantitation were: control n¼ 28, 1mM cap. n¼ 14, 2mM EGTA n¼ 21, 2mM EGTA þ 1mM cap. n¼ 21, 1mgml 1
TrkA-Fc n¼ 21, 1mgml 1 TrkA-Fc þ 1mM cap. n¼ 21, 0.4mgml 1 TrkB-Fc n¼ 19, 0.4mgml 1 TrkB-Fc þ 1mM cap. n¼ 20; from four cultures. Error¼ s.e.m.,
signiﬁcance determined by one way ANOVA with Tukey’s post hoc test for multiple comparisons, ***Po0.001. (g) Immunostains of EGFP and TRPV1-IRES-GFP
transfected hippocampal neurons with NGF. Quantitation of NGF intensity in somas of transfected neurons is indicated on the right (n¼ 12 images from three
cultures; error¼ s.e.m., signiﬁcance determined by unpaired Student’s t-test with Welch’s correction). (h) Immunostains of EGFP and TRPV1-IRES-GFP
transfected hippocampal neurons with BDNF. Quantiﬁcation of BDNF intensity in somas of EGFP and TRPV1-IRES-GFP transfected neurons with and without
addition of 1mM SB-366791 2 days after transfection, is indicated on the right (n¼ 13 images from three cultures; error¼ s.e.m., signiﬁcance determined by
unpaired Student’s t-test with Welch’s correction, ***Po0.001). Scale bars, 20mm in all panels.
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms15878
12 NATURE COMMUNICATIONS | 8:15878 | DOI: 10.1038/ncomms15878 | www.nature.com/naturecommunications
CA1
CA3
Stimulate Record
DG
b c
TRPV1-expressing
OLM cell
SO
SP
SR
SLM
SC
TA
a
d
g
Baseline 40 Hz 1 s Recovery 5 μM nic. Recovery 1 μM cap. Recovery
TRPV1 CHRNB2 SOM Merge
SO
SP
SR
0
10
20
30
40
50
60
70
80
90
100
%
 P
os
iti
ve
 c
el
ls
Both
CHRNB2
Marker
5 mv
5 ms
–20 0 20 40 60
75
100
125
150
175
Time (min)
fE
PS
P 
(m
V/
ms
) %
TRPV1 KO
Wild-type
5 mv
5 ms
i
–20 0 20 40 60
75
100
125
150
175
Time (min)
fE
PS
P 
(m
V/
ms
) %
TRPV1 KO + nic.
TRPV1 KO
Wild-type
Wild-type + nic.
f
50 100 150 200
−1
1
2
3
4
0
Time (s)
ΔF
/ F
40 Hz 1 s
5 μM nic. 1 μM cap.
0
h
–20 0 20 40 60
75
100
125
150
175
Time (min)
fE
PS
P 
(m
V/
ms
) %
TRPV1 KO + nic.
TRPV1 KO
TRPV1 KO + nic. + DHBE + MLA
TRPV1 KO + nic. + DHBE + MLA + MEC
5 mv
5 ms
j
e
TRPV1 CHRNB2 Reelin Merge
SO
SP
SR
TR
PV
1
SO
M
Re
elin
Figure 9 | TRPV1 affects synaptic plasticity in the Schaffer collateral pathway via promoting innervation of OLM cells. (a) Scheme of putative
connections of a TRPV1-expressing OLM cell in the stratum oriens. OLM cells inhibit the temporoammonic (TA) pathway from the entorhinal cortex, and
disinhibit the Schaffer collateral pathway from the CA3 region, thus promoting CA3 input, and reducing EC input, to CA1 pyramidal cells. (b) Illustration of
stimulating and recording electrode positions for LTP recordings performed in the Schaffer collateral pathway. (c) LTP induced by 1XTET-LTP in the Schaffer
collateral pathway is reduced in TRPV1 KOs compared WT (n¼ 10 sections each from WT and TRPV1 KO mice; error¼ s.e.m.). (d) Immunostain of
hippocampal sections from a b2-EGFP nAChR mouse with TRPV1 and SOM, and with TRPV1 and reelin (e); TRPV1 and b2-EGFP nAChRs are expressed in
the same population of OLM neurons. (f) Quantitation of b2-EGFP nAChR with TRPV1, SOM, and reelin-expressing cells in the stratum oriens (n¼8, 4 and
3 images for TRPV1, SOM, and reelin, respectively, from four hippocampal sections). (g) Calcium imaging of Fluo-4 signal in dissociated hippocampal
neurons stimulated sequentially with 5 mM nicotine and 1mM capsaicin. 80% of cells that responded to capsaicin also responded to nicotine; of 112 cells
that responded to ﬁeld stimulation, 17 responded to nicotine and capsaicin, four to capsaicin alone, and 22 to nicotine alone. (h) Representative traces of
hippocampal neurons responding to both nicotine and capsaicin. (i) LTP in the Schaffer collateral pathway of TRPV1 KOs is restored to WT levels by 5 mM
nicotine exposure 20min before and during recording (n¼ 10 slices each for WT, TRPV1 KO, WT þ nicotine, and TRPV1 KO þ nicotine; signiﬁcance
determined by Student’s t-test, error¼ s.e.m.). (j) The rescue of LTP in TRPV1 KOs by nicotine is not mediated by a4b2 or a7-containing nicotinic
receptors—blocked by 100nM DHBE and 100 nM MLA, respectively—but is mediated by a2 receptors blocked by addition of 1 mM MEC, which blocks all
nicotinic receptors including a2 (n¼ 7 slices each for TRPV1 KO þ nicotine/DHBE/MLA and for TRPV1 KO þ nicotine/DHBE/MLA/MEC; error¼ s.e.m.).
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defects. Most highly nicotine-sensitive nicotinic acetylcholine
receptors contain the b2-subunit (CHRNB2). We therefore
ﬁrst examined the localization of TRPV1 and CHRNB2 in
OLM neurons. We used a knock-in mouse strain in which all
b2-subunits contain an EGFP moiety fused in frame to the
b2-subunit46. We found that indeed, TRPV1 co-localized with
cells expressing CHRNB2 subunits and both somatostatin
(Fig. 9d) and reelin (Fig. 9e) in OLM neurons in the stratum
oriens. Quantitation indicated that 89.5% of CHRNB2-positive
cells in the stratum oriens also expressed TRPV1; CHRNB2-
expressing cells were also largely positive for somatostatin and
reelin (Fig. 9f). We further tested if TRPV1-expressing hippo-
campal neurons (that is, neurons responding to capsaicin), also
responded to nicotine in Ca2þ imaging experiments (Fig. 9g).
We found that, indeed, 80% of neurons that responded to
capsaicin also responded to nicotine (Fig. 9h). We then tested if
acute application of nicotine to hippocampal slices to activate
OLM neurons would rescue LTP deﬁcits in TRPV1 knockouts by
bypassing the excitatory innervation defects of OLM neurons.
Treatment of WT hippocampal slices with 5 mM nicotine before
and during LTP recordings caused a mild increase in LTP, as
previously reported45. While treatment of TRPV1 knockout
hippocampal slices with 5 mM nicotine before and during LTP
recordings indeed rescued LTP to levels similar to WT slices with
nicotine (Fig. 9i).
Nicotinic receptors are present on almost all interneuron
subtypes in the hippocampus47–50, each of which could mediate
rescue of LTP in TRPV1 knockouts. For example, intermediate
(presumably bistratiﬁed) interneurons innervated by OLM
neurons35 may respond to nicotine, and VIP neurons that
control OLM cells51 are also strongly responsive to nicotine52.
Nicotinic receptor subunits a2–5, and b2–4 have been found in
the hippocampus53, of which a4b2, a7 and a2 subunits are present
functionally47. a2 is speciﬁcally expressed in OLM cells35,54, has a
slow non-desensitizing nicotinic response—unlike a7 and a4
(ref. 47), and is necessary for the gating of LTP45. We therefore
hypothesized that rescue of LTP in TRPV1 knockouts by nicotine is
mediated speciﬁcally by a2 receptors on OLM cells. To test this, we
isolated a2 from a4b2 and a7 pharmacologically. Application of
100nM MLA and 100 nM DHBE to block a7 and a4b2 receptors,
respectively52,55, did not block rescue of LTP in TRPV1 knockouts
by nicotine (Fig. 9j)—indicating that rescue was indeed mediated
speciﬁcally via a2 receptors in OLM neurons. To conﬁrm the role
of a2 receptors we then added 1mMMEC, a non-selective nicotinic
agonist47, which blocked rescue of LTP in TRPV1 knockouts by
nicotine (Fig. 9j).
We propose a mechanism by which TRPV1 exerts a chronic
effect on excitatory innervation of OLM cells to affect plasticity,
rather than an acute effect of TRPV1 channel activation during
LTP. If this is the case one would expect no effect of acute
blockade or activation of TRPV1 on LTP. To test this, we added
1 mM capsaicin or 1mM SB-366791 30min before induction of
LTP to activate or block TRPV1 channels, respectively. We found
no signiﬁcant effects of capsaicin or SB-366791 on LTP compared
to control (Supplementary Fig. 7), consistent with our hypothesis
that TRPV1-mediated effects on LTP result from innervation of
OLM cells.
Together, our results demonstrate that post-synaptic TRPV1 in
OLM cells promotes excitatory innervation of these cells to affect
hippocampal plasticity.
Discussion
We discovered that TRPV1 is expressed in, and promotes
excitatory innervation of, OLM interneurons in the hippocampus,
which are essential for the gating of information ﬂow in the
hippocampus. TRPV1-positive cells expressed somatostatin, a
common marker for OLM neurons25,56, and also expressed reelin.
Only 20% of TRPV1-expressing cells were parvalbumin-positive.
Interestingly, a recent study found that reelin and somatostatin
intersectional expression is restricted to OLM cells, of which there
are at least two types: both express somatostatin and mGluR1, but
one expresses parvalbumin31 and originates from the medial
ganglionic eminence while the other originates from the caudal
ganglionic eminence and expresses reelin and the serotonin
receptor 5-HT3AR28. Our data suggest that TRPV1-expressing
cells belong predominantly to the latter sub-population of OLM
neurons. We found that these cells also express b2* nAChRs,
probably a2b2 (ref. 35), and capsaicin-responsive neurons also
responded to nicotine in Ca2þ -imaging experiments. A previous
study failed to detect Ca2þ inﬂux using a 10-fold higher capsaicin
concentration10, but this study focused only on neurons of the
dentate gyrus and therefore may have missed responses of
TRPV1-expressing cells in the stratum oriens.
Perhaps the most striking discovery in our study was that post-
synaptic TRPV1 in OLM neurons promotes the formation of
exuberant excitatory synapses—presumably from CA1 pyramidal
neurons57,58—onto these neurons. The functional state of the
channel was important since capsaicin increased excitatory
synapse number in a dose-dependent manner, and blockade or
knockout of TRPV1 dramatically decreased the number of
excitatory synapses on OLM neurons. Moreover, heterologous
TRPV1 expression in cells that do not normally express it,
increased the strength and number of excitatory synapses onto
these neurons. To our knowledge, our study is the ﬁrst to reveal
how innervation of OLM neurons is regulated. A recent study
reported that ElfN1 recruits mGluR7 receptors to excitatory
terminals contacting OLM cells, and decreases glutamatergic
release probability—but without affecting the number of
excitatory synapses on OLM neurons59. TRPV1 then emerges
as a candidate molecule that regulates excitatory synaptic strength
by modulating glutamatergic innervation of OLM neurons.
At higher capsaicin levels (1 mM) synaptic vesicle recycling in
excitatory terminals was reduced in both TRPV1-expressing and
non-TRPV1-expressing neurons. This is similar to reported
effects of acute capsaicin application, which reduced presynaptic
excitatory strength14,15,60. TRPV1 did not signiﬁcantly affect
inhibitory synapse number or strength. Expression of TRPV1 in
neurons normally lacking it; however, decreased inhibitory
presynaptic strength in contacting terminals—similar to a
recent report that capsaicin depresses GABAergic synaptic
transmission in the dentate gyrus61, without changing
inhibitory synapse number.
We propose a pathway whereby NGF upregulates TRPV1 in
OLM neurons, which, when activated, leads to increased calcium
inﬂux. This activates BDNF expression, which then promotes
excitatory innervation of these cells. This pathway is supported by
our ﬁndings that TRPV1-expressing neurons have higher NGF
levels than non-TRPV1-expressing neurons, and that NGF
upregulates TRPV1 in hippocampal cultures. This is similar to
the peripheral nervous system, where NGF upregulates TRPV1 in
nociceptors33,34. In the hippocampus, NGF is retrogradely trafﬁ-
cked to septal cholinergic neurons—which innervate OLM
cells35—and promotes their survival36. Thus post-synaptic
TRPV1 may be important for cholinergic, as well as glutama-
tergic innervation. Interestingly, exogenous NGF increases
Schaffer collateral LTP, and blockade of endogenous NGF
reduces LTP62, similar to the effects of increasing or blocking
TRPV1 function.
A number of endogenous ligands may activate TRPV1 to
increase excitatory innervation of OLM neurons. Several endova-
nilloids have been found to activate TRPV1 in the hippocampus,
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including 12-HPETE14, anandamide15,63 and N-arachydonoyl-
dopamine (NADA)64. 2-arachidonylglicerol (2-AG) and N-oleoyl-
ethanolamide are also present in the hippocampus and can activate
TRPV1. Many of these endovanilloids can activate receptors
besides TRPV1. Anandamide and 2-AG, for example, are classiﬁed
as endocannabinoids because they activate the cannabinoid
receptor 1 (CB1) in addition to TRPV1 (refs 15,60,65). Because
TRPV1 ligands can activate other receptors, and TRPV1 can be
activated by multiple ligands it is possible that more than one
endogenous ligand promotes excitatory innervation of OLM cells,
potentially at different times, or in response to distinct stimuli.
What are the circuit consequences of reduced excitatory
innervation of OLM cells in TRPV1 knockouts? OLM neurons
control information ﬂow in the hippocampus by directly
inhibiting distal dendrites of CA1 neurons in the temporoam-
monic pathway from the entorhinal cortex, and disinhibiting the
Schaffer collateral pathway via connections to feedforward inhi-
bitory interneurons in the stratum radiatum35,56. A reduction in
excitatory innervation of OLM neurons would therefore be
expected to decrease disinhibition, and subsequently decrease
LTP, in the Schaffer collateral pathway. Indeed, we found a
reduction in LTP in TRPV1 knockouts in the Schaffer collateral
pathway, as previously reported11,22. Because OLM neurons
directly inhibit the temporoammonic branch of the perforant
pathway from the entorhinal cortex35, TRPV1 knockouts would
also be expected to have increased temporoammonic LTP from
the perforant path. Interestingly, TRPV1 knockouts do have
increased LTP in the medial perforant pathway of the dentate
gyrus15. However, the medial perforant pathway is presumably
not affected by OLM cells. The increased LTP in this pathway in
TRPV1 knockouts might rather be due to TRPV1-mediated LTD
at the medial perforant path—dentate granular cell synapse15.
We hypothesized that if the deﬁcit in LTP in TRPV1 knockouts
is due to decreased excitatory innervation of OLM neurons,
bypassing this innervation defect by activating OLM neurons
should rescue LTP in TRPV1 knockouts. Application of nicotine
completely rescued the LTP deﬁcit in TRPV1 KOs to WT levels
via the a2 nicotinic receptor subunit, which is speciﬁcally
expressed in OLM neurons35,54. This conﬁrms that the LTP
deﬁcit observed in TRPV1 knockouts is likely due to decreased
excitatory innervation of OLM neurons. In agreement with this
hypothesis, we found no effect of acute application of capsaicin
or the TRPV1 channel blocker SB-366791 on LTP. Previous
studies also report no effect of SB-366791 (ref. 12), or the
TRPV1 antagonist capsazepine13 on LTP. However, these studies
do report an increase in LTP with addition of capsaicin12,13;
a 1,000-fold higher concentration of capsaicin was used in the
former publication, and a theta burst protocol was used in the
latter. It is therefore likely that the concentration of capsaicin
or induction protocol may affect the degree of potentiation of
LTP by capsaicin.
Gibson et al.14, described a TRPV1-mediated depression of
stratum radiatum interneuron responses during high-frequency
stimulation of the Schaffer collateral, which was absent in TRPV1
knockouts. This would result in excess inhibition of pyramidal
neurons and reduced Schaffer collateral LTP in TRPV1
knockouts (which we, and others have observed11,22). Our
model is largely in agreement with Gibson et al., except for
where TRPV1 is located. We both agree that TRPV1 affects
stratum radiatum interneurons, but is not present in stratum
radiatum interneurons themselves–based on immunostaining in
our case, and absence of blockade of depression by introducing
TRPV1 blockers into recorded stratum radiatum interneurons in
Gibson et al. In terms of TRPV1 location, however, Gibson et al.
proposed that TRPV1 is presynaptic on pyramidal neurons,
where it reduces transmitter release onto post-synaptic stratum
radiatum interneurons during high-frequency stimulation of the
Schaffer collateral. We propose that TRPV1 is present in OLM
neurons that contact stratum radiatum interneurons, where
TRPV1 promotes excitatory innervation of OLM neurons.
This would also act to depress stratum radiatum interneurons
(via disinhibition) during stimulation of the Schaffer collateral
pathway. We favour this model because we observed capsaicin
responses and TRPV1 staining speciﬁcally in OLM neurons
(and not in TRPV1 knockouts), and because speciﬁc activation of
OLM neurons by a2-nicotinic receptors-rescued LTP in TRPV1
knockouts. However, it remains possible that both pathways
could work in parallel.
The presence of TRPV1 in OLM neurons also may explain the
observation that OLM neurons become especially hyper-excitable
at febrile temperatures (40–43 C) (ref. 66). TRPV1 could
participate in the aetiology of febrile seizures. In animals with
persistent epileptic seizures the ﬁring frequency of OLM
interneurons shifts from normal theta frequency17,25 to gamma
oscillations, possibly due to enhanced frequency of excitatory
input67. This, in turn changes the excitability of the entire
neuronal network68. OLM cells can therefore have profound
effects on the total excitatory and inhibitory output of the
hippocampal system. Interestingly, a subset of OLM cells with
high excitation are recruited during hippocampal sharp wave
ripple events69. These events are important for memory
consolidation and reactivation of place cells70. TRPV1 may be
involved in sharp wave ripples—by promoting high excitatory
innervation of this subset of OLM neurons—and therefore
important for intrahippocampal information processing
necessary for spatial memory.
Methods
Animals. Use of animals for experimentation, including TRPV1 knockout1
(B6.129X1-Trpv1tm1Jul/J), PV-Tomato (B6;129P2-Pvalbtm1(cre)Arbr/JB6;129S6-
Gt(ROSA)26Sortm9(CAG-tdTomato)Hze/J) and VIP-Tomato (Viptm1(cre)Zjh/
JB6;129S6-Gt(ROSA)26Sortm9(CAG-tdTomato)Hze/J) reporter mice, all acquired
from The Jackson Laboratory, was approved and performed according to the
speciﬁcations of the Institutional Animal Care and Ethics Committees of Go¨ttingen
University (T10.31 and T10.24), and of the German animal welfare laws. Use of
b2-EGFP nAChR mice46 was approved by the Institutional Animal Care and Ethics
Committee at Lehigh University (protocol number 147).
Plasmids and expression constructs. In initial experiments we used
TRPV1-IRES-EGFP (provided by Gero Miesenboeck) compared to cytosolic
enhanced green ﬂuorescent protein (EGFP) to test the effects of TRPV1 expression
on synapse formation and function. In subsequent experiments, we generated new
plasmids TRPV1-P2A-EGFP and VR.50 sv-P2A-RFP using the chicken b-actin
promoter to drive expression of TRPV1 and VR.50 sv proteins co-expressing EGFP
(with TRPV1) or RFP (with VR.50 sv) using the P2A multicistronic element. The
b-actin promoter-driven TRPV1-P2A-EGFP and VR.50 sv-P2A-RFP plasmids were
sub-cloned by GenScript (Piscataway, NJ, USA). Synapsin promoter-driven EGFP
and ChR2-EYFP AAV vectors were provided by Karl Deisseroth (Stanford
University).
Antibodies and reagents. Primary antibodies used were: chick and rabbit EGFP
(1:4,000 dilution; Abcam), mouse GAD65 (1:1,000), guinea pig (1:800 for uptake)
and mouse syt1 (1:150 for uptake), rabbit alpha tubulin (1:5,000), mouse syb2
(1:1,000 dilution; Synaptic Systems), chick and mouse MAP2 (1:4,000 dilution;
Millipore), sheep NGF, mouse reelin, guinea pig TRPV1 C-T (1:1,000, Millipore),
mouse TRPV1 N-T (1:500; Neuromab), rabbit TRPV2, TRPV3, TRPV4 (1:500;
Alomone), rabbit mGluR7 (1:500; Upstate), mouse PV25 (1:2,000 dilution; Swant),
rabbit Somatostatin-14 (1:2,000 dilution; Bachem), rat Somatostatin-14 (1:1,000
dilution; Thermo Fisher), rabbit VIP (1:500 dilution; Abcam), mouse BDNF (1:500;
Developmental Studies Hybridoma Bank; Yves Barde monoclonal #9). Secondary
antibodies used were: guinea pig, mouse and rabbit HRP (1:5,000 dilution; BioRad)
and chick, rabbit, guinea pig, mouse, rat and sheep Alexa 405, 488, 546 and 647
(1:2,000 dilution; Abcam/Invitrogen). Neurotrace was from Thermo Fisher.
Capsaicin and SB-366791 were purchased from Sigma-Aldrich.
Methyllycaconitine (MLA) was from Abcam and dihydro-beta-erythroidine
(DHBE), mecamylamine (MEC) picrotoxin, TTX, APV and CNQX were from
Tocris. Recombinant Human TrkA Fc and TrkB Fc Chimera Proteins were from
R & D Systems. All other reagents were from Carl Roth.
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Dissociated rat hippocampal neuron preparation. E18 pregnant Wistar rats
were killed with CO2, embryos were removed, and heads of embryos were placed in
a 10 cm petri dish containing ice-cold dissection media (HBSS (Gibco) þ 10mM
Hepes (Gibco)). Brains were removed and collected in fresh dissection medium.
Hippocampi were separated from the brain and meninges were removed.
Hippocampi were digested with 2ml pre-warmed 37 C 0.05% trypsin-EDTA
(Gibco) for 20min at 37 C. Trypsin was removed and the tissue was washed three
times with 4 C dissection medium. Dissection medium was replaced with 1ml
pre-warmed NBþ (Neurobasal with 1X B-27 supplement, 1X Glutamax and
Penicillin (5,000Uml 1)/Streptomycin (5000 mgml 1); all from Gibco) and tissue
was triturated by gentle pipetting. The tissue suspension was ﬁltered through a
100mm cell strainer (BD Biosciences). Cells were counted using the trypan blue
exclusion method and cultured on 12mm glass coverslips (Thermo Scientiﬁc)
coated with poly-D-lysine (PDL, Sigma) dissolved in 0.1M borate buffer, in
24-well plates (CytoOne) at a density of 80,000 hippocampal neurons per cm2 in
NBþ medium in a Hera Cell 240i cell culture incubator (Thermo Scientiﬁc) at
37 C and 5% CO2.
Dissociated mouse hippocampal neuron preparation. TRPV1 knockout mice1
were purchased from Jackson Laboratory. P0 TRPV1 knockout and WT mice of
both sexes were dissected successively; pups were decapitated and heads placed on
a petri dish and sprayed with 70% ethanol. The skin of the scalp was separated,
skull was opened, and the brain was removed and placed in a petri dish containing
4 C dissection medium. Hippocampal dissection was performed as for rat
embryonic hippocampal dissection with a few modiﬁcations. Hippocampi were
digested with either 2ml pre-warmed 37 C 0.05% trypsin-EDTA (Gibco) for
20min at 37 C, or ﬁltered papain-based enzymatic solution (11.39mM L-cysteine,
50mM Na-EDTA (pH¼ 8), 100mM CaCl2, 1 N NaOH, 100ml papain
(Worthington) (added to the solution 15min before use) and 10mgml 1 of
DNAseI (added just before digestion) for 30min at 37 C. For trypsin digestion,
trypsin was removed and the tissue was washed three times with 4 C dissection
medium. Dissection medium was replaced with 1ml pre-warmed NBþ
(Neurobasal with 1X B-27 supplement, 1X Glutamax and Penicillin
(5,000Uml 1)/Streptomycin (5,000 mgml 1); all from Gibco) and tissue was
triturated by gentle pipetting. For papain digestion, the enzymatic solution was
removed and replaced by an inactivation solution (BSA, 5% serum medium and
10mgml 1 of DNAseI) at 37 C for 15min. Subsequently the tissue was triturated
and then centrifuged in an Eppendorf 5810-12 centrifuge at 500 g, the supernatant
was discarded and replaced with fresh NBþ , and the tissue pellet was resuspended
before plating neurons at a density of 120,000 cells per cm2.
Transfection of dissociated rat hippocampal neurons. To achieve low-efﬁciency
heterologous expression of TRPV1 and VR.50 sv in single neurons, lipofectamine-
based transfections were performed in cultured rat or mouse hippocampal neurons
at DIV2. For each well of a 24-well plate, 0.75 mg of plasmid DNA and 1 ml of the
cationic lipid-based transfection reagent Lipofectamine 2000 (Invitrogen). were
each diluted in 50 ml of 4 C Neurobasal in separate tubes and incubated for 5min
at room temperature (RT). Subsequently, both dilutions were mixed together
and incubated at RT for 20min. During this time, the culture medium from
each well to be transfected was exchanged with 400 ml of new pre-warmed
NBþ (Neurobasal with 1X B-27 supplement, 1X Glutamax and penicillin
(5,000Uml 1)/streptomycin (5,000 mgml 1); all from Gibco) at 37 C; the ori-
ginal culture medium was stored at 37 C and 5% CO2. After incubation, 100ml of
the lipofectamine-DNA mix was added to each well for a ﬁnal volume of 500 ml per
well. Cultures were incubated for 2 h at 37 C and 5% CO2. Transfection medium
was then removed, and wells were washed once with 500 ml Neurobasal at 37 C,
and 450ml of the original culture medium at 37 C was added back to the wells.
Reporter gene expression was normally detected 2 days after transfection.
ChR2-EYFP AAV production, transduction and LED stimulation. Recombinant
AAV serotype 1/2 particles were generated by transfecting 60% conﬂuent HEK293
cells in 10 cm dishes (Greiner Bio-One) cultured at 37 C and 5% CO2 in 10ml of
medium consisting of DMEM, 10% fetal bovine serum, 100Uml 1 penicillin and
100mgml 1 streptomycin (all from Gibco), using calcium phosphate transfection.
For one 10 cm dish, 150 ml 2M CaCl2, 80 mg plasmid DNA (20mg EGFP or ChR2-
EYFP expression vector, 40 mg adenovirus helper plasmid pFD6 and 10 mg each of
AAV1 (pH21) and AAV2 (pRV1) replication and capsid sequence plasmids),
and dH2O to a ﬁnal volume of 1,200ml was mixed dropwise with 1,200 ml
transfection buffer (in mM: 274 NaCl, 10 KCl, 1.4 Na2HPO4, 15 glucose,
42 HEPES; ph¼ 7.05–7.12, sterile ﬁltered). This mixture was incubated for 20min
at room temperature, and then added dropwise to 10 cm dishes of HEK293 cells at
60% conﬂuence. 48–72 h post transfection, cells were harvested in 500 ml DPBS and
lysed by four repeated freezing ( 80 C) and thawing (37 C) cycles. Cell debris
was removed by centrifuging at 10,000 r.c.f. for 5min. The supernatant, containing
crude AAV extract was collected and stored at 4 C. For viral transduction, 1–2 ml
of this supernatant was applied per well of six-well plates of dissociated hippo-
campal cultures at DIV3, to achieve a transduction efﬁciency of 480% by DIV13.
On DIV13, EGFP or ChR2-EYFP transduced neurons were transferred to a
custom-built LED chamber containing 100mW blue LEDs (Conrad) operated at
3.2 V with an output of 0.1mWmm 2, placed beneath a polyoxymethylene light
diffuser (Kern GmbH) 20mm below the cells. A micro-controller connected to a
power supply delivered three light pulses of 100ms duration every 1.5 s to
cultures in the incubator for 21–24 h. Following stimulation, cultures were ﬁxed,
immunostained for EGFP or EYFP, TRPV1, vGluT1 and MAP2, and number of
synapses quantiﬁed as below.
Synaptotagmin 1 luminal domain antibody uptake. For synaptotagmin-1
luminal domain antibody uptake (syt1u) dissociated hippocampal neurons were
incubated for 10min at 37 C in 250 ml high potassium depolarizing buffer
(75mM NaCl, 70mM KCl, 20mM Hepes, 2mM CaCl2, 5,5mM glucose
2mM MgCl2, and 20mM Hepes; pH 7.3) containing syt 1 luminal domain speciﬁc
antibodies. Depolarizing buffer was then removed and samples were ﬁxed for
immunostaining.
Immunocytochemistry. Dissociated hippocampal cultures growing on glass
coverslips were ﬁxed with 250 ml 4% paraformaldehyde (PFA) diluted in 0.1M
phosphate buffer (PB) (0.1M Na2HPO4, 0.1M NaH2PO4 dissolved in ddH2O;
pH 7.4) for 20–30min at room temperature. Fixed hippocampal cultures were then
washed three times with 500 ml 1 PBS (and stored up to one month at
4 C in 1 PBS). Dissociated cultures were then incubated for 20min at room
temperature in 250 ml blocking buffer containing Triton X-100 for permeabilization
(2% [v/v] donkey serum, 0,1% (v/v) Triton X-100 (Carl Roth), 0,05% (v/v) NaN3 in
2X PBS). Samples were then incubated with primary antibodies in blocking buffer
overnight at 4 C. The solution containing primary antibodies was discarded and
cells were washed three times for 5min each with 500 ml 1 PBS. Cells were then
incubated for 2 h at room temperature in the dark in 250ml blocking buffer
containing secondary antibodies conjugated to a ﬂuorophore. Secondary antibody
solution was then removed and cells were washed three times for 5min each with
1 PBS. For DAPI staining samples were incubated for 10min in 250 ml 1 PBS
containing 10mM DAPI (Invitrogen) at room temperature in darkness and washed
three times for 5min each with 1 PBS. The same primary or secondary
antibody mix was used for different conditions or treatments within the same
experiment. Coverslips were mounted with a drop (10ml) of Fluoromount Plus
(Diagnostic Biosystems) or Fluoromount-G (Sigma) on glass slides (Carl Roth).
Coverslips were sealed using transparent nail polish, and then imaged by
epiﬂuorescence and confocal microscopy.
Immunohistochemistry and paraformaldehyde perfusion ﬁxation. Two- to
three-month old WT (B6/J), TRPV1 KO, PV-Tomato, VIP-Tomato and
3–5-month-old b2-EGFP nAChR mice of both sexes were anaesthetized by
intraperitoneal injection of a tranquilizer cocktail containing 10% ketamine,
2% xylazine and 0.9% saline solution or pentabarbitol solution for the b2-EGFP
nAChR mice (0.1ml per 10mg body weight). After anaesthetization mice were
placed on a perfusion chamber (abdomen side up) and fastened with needles. The
rib cage was removed and once the heart was successfully exposed, the right atrium
was cut and a winged needle connected to a peristaltic pump (Masterﬂex) was
inserted into the left ventricle. The blood was drained by perfusion of pre-ﬁltered
sucrose solution (10% sucrose (Carl Roth) in ddH2O) for B1min followed by
B50ml of pre-ﬁltered 4% PFA at RT for B20min (for ﬁxation). A successful
perfusion was detected when the tail of the animal became stiff. The brain was
subsequently dissected out of the skull, incubated in sterile-ﬁltered 4% PFA at 4 C
for 2 h, and washed twice for 15min each with 0.1M PB. Tissue was then used for
IHC or stored in PB at 4 C for up to a month. All buffers and solutions were
freshly prepared for every perfusion. For the b2-EGFP nAChR mice, the same
procedure was used as above, except that a PBS wash was performed before
4% PFA perfusion, and brains were post ﬁxed in 4% PFA o/n at RT and then
switched to 1% PFA solution for storage.
Immunohistochemistry of mouse brain sections. Before tissue sectioning,
2–3-month-old ﬁxed mouse brains were pre-sectioned using an acrylic brain
blocker (Kopf Instruments) to remove the most frontal and caudal parts of the
brain to keep the starting point for slicing similar for every brain. Coronal brain
sections were generated using a Leica VT 1200 vibratome (Leica Biosystems): Pre-
sectioned brains were stabilized caudally with Roti coll 1 superglue (Carl Roth) on a
specimen disc ﬁxed to the vibratome’s buffer tray. The tray was then ﬁlled with
4 C 0.1M PB. The system was calibrated and 40-mm-thick coronal sections were
cut using a razor blade (Astra Platinum). Each slice was collected in individual
wells of a 24-well plate containing 4 C 0.1M PB and stored up to a month at 4 C.
Brain sections were visually selected for immunohistochemistry using an Axiovert
40 CFL (Zeiss). Comparable sections between different brains from different
samples were sorted and classiﬁed depending on their approximate stereotactic
coordinates according to Paxinos and Franklin71. Sections were washed ﬁrst with
50mM Tris buffer (TB) (38.5mM Tris-HCl; 11.5mM in ddH2O; pH 7.6), then
with Tris-buffered saline (TBS) (0.9% NaCl in TB, pH 7.6) and ﬁnally with
Tris-buffered saline with Triton X-100 (TBST) (0.5% [v/v] 100X Triton X-100 in
TBS; pH 7.6). Every washing step was done twice for 15min each at RT. sections
were then incubated for 90min in blocking buffer, and then in 500 ml blocking
buffer containing primary antibodies for 48–72 h at 4 C on an orbital shaker.
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Subsequently, tissue was washed 4 15min with TBST at RT. Then tissue was
incubated for 2 h at RT in 500ml blocking buffer containing secondary antibodies
in darkness. Tissue was then washed with TBST (2 15min) and with TBS
(1 15min) at RT. For DAPI staining the tissue was incubated for 10min in 500 ml
1 PBS containing 10mM DAPI (Invitrogen) at RT in darkness. Tissue was then
washed at RT once for 15min with TBS and then two times for 15min each with
TB. Brain sections were mounted on glass slides (Carl Roth) with a drop (10 ml) of
Fluoromount-G (Sigma) and covered with 12mm glass coverslips (Thermo
Scientiﬁc). Coverslips were sealed using transparent nail polish and imaged by
confocal microscopy.
Microscopy. Immunostained dissociated hippocampal neuronal cultures on glass
coverslips were imaged by epiﬂuorescence using an upright Zeiss Axiovert.A1
microscope (Carl Zeiss) with a  100/1.4 oil Plan-Apochromat objective or a
 63/1.4 oil Plan-Apochromat objective (Carl Zeiss). Images were captured with a
Retiga-SRV camera (QImaging) and QCapture software (QImaging). Three to ten
pictures of different neurons/regions of a given condition within the same
experiment were acquired using identical settings for image size, light intensity,
gain and exposure time. Confocal microscopy was conducted using a Zeiss LSM
710 confocal microscope (Carl Zeiss) with a  40 Plan-Neoﬂuar oil immersion
objective or  20 Plan-Apochromat air objective. A diode laser was used to
excite the Alexa 405 ﬂuorophore (excitation–emission: 401–421 nm) and DAPI
(emission: 410–495 nm). The Alexa 488 ﬂuorophore (excitation–emission:
493–520 nm) was excited with a 488 nm argon laser. The Alexa 546 ﬂuorophore
was excited with a DPSSL laser (excitation–emission: 556–573 nm) and the Alexa
647 ﬂuorophore was excited with a HeNe laser (excitation–emission: 650–665 nm).
A minimum of three images of hippocampal sections or neurons within the same
experiment were acquired with identical frame size, scan speed, zoom, laser
intensity, master gain, pinhole airy units, digital offset and digital gain. Images were
captured and saved using ZEN 2009 software and exported as 8-bit RGB tiff ﬁles.
Synaptic strength and synapse number quantitation. To optically measure
synaptic strength of hippocampal neurons in vitro we co-immunostained for syt1
uptake to mark recycling synaptic vesicles and vGluT1, to mark synaptic vesicles at
excitatory presynaptic terminals, or vGAT, to mark synaptic vesicles at inhibitory
presynaptic terminals (or with BDNF in experiments comparing BDNF puncta
intensity on WT and TRPV1 knockout neurons). The intensity of vGluT1 or vGAT
signal corresponds to the number of synaptic vesicles per terminal and, in
conjunction with syt1 uptake, gives a readout of presynaptic strength.
A mask of the transfected cell was created according to GFP or RFP
ﬂuorescence for transfected neurons, or endogenous TRPV1 or SOM/reelin
immunostain signal, using Adobe Photoshop CS5 software (Adobe Systems
Incorporated). All synaptic puncta positive for vGluT1 or vGAT on single
transfected neurons within the mask were selected using OpenView 3.0 software
(provided by Noam Ziv, Technion, Israel Institute of Technology, Haifa, Israel).
The ﬂuorescent intensity of vGluT1 or vGAT signal was measured using the
‘place area over puncta’ function; threshold and delta intensity were conﬁgured for
an accurate selection of synapses. Fluorescence intensity of puncta within the
transfected neuron mask reported presynaptic strength on the selected neuron. The
corresponding ﬂuorescence intensity of the co-stained syt1 antibody taken up by
recycling synaptic vesicles within selected areas was also measured. Blurry regions,
puncta on somas and puncta not overlapping a visible neuronal process were
excluded from analysis.
The values for ﬂuorescence intensity generated by OpenView 3.0 were imported
into Microsoft Excel. To compare conditions in multiple experiments, the
ﬂuorescence intensities in different conditions within a single experiment
(a neuronal cell preparation in which ICC for all conditions was performed using
the same antibody mix) were normalized to a range from 1 to 100, where 1
corresponded to the lowest and 100 to the highest ﬂuorescence intensity detected in
the experiment using the formula:
x ¼ imin
maxmin100;
where x¼ normalized value, i¼ intensity value calculated by OpenView 3.0,
min¼ lowest intensity value of the experiment and max¼ highest intensity value of
the experiment. The ﬂuorescence intensity of puncta in every image was averaged
and the mean of the average ﬂuorescent intensity across all experiments for
multiple images was calculated for each condition. Pooled data of all images for
every condition were plotted with the standard error of the mean. BDNF puncta
intensity on WT and TRPV1 knockout neurons was determined using a similar
method by thresholding puncta using OpenView 3.0 software.
Synapse number (or BDNF puncta number) was analysed by visual selection
and counting of puncta positive for vGluT1 or vGAT (or BDNF)
immunoﬂuorescence overlapping EGFP or MAP2—a marker of dendrites in
mature neurons. Synapses were counted along 2–3 randomly selected 30–50 mm
long segments of proximal dendritic processes per neuron. Since TRPV1-
expressing neurons have dense innervation where synapses are tightly packed,
making the identiﬁcation of individual synapses difﬁcult, MetaMorph (Molecular
Devices) software was used to calculate the number of synapses contacting these
neurons. The ﬂuorescent signal of vGluT1 and vGAT-positive immunostainings
was selected by thresholding the signal (using the ‘set colour threshold’ function) to
a speciﬁc level where only synapses were selected. Then, the ‘threshold’ intensity
value of a randomly selected 30–50 mm length of a proximal dendrite was used to
calculate the number of synapses in this area using the following formula:
n ¼ i=d
l=p
;
where n¼ number of synapses, i¼ average ﬂuorescence intensity in a selected
thresholded area, d¼ average area of a single synapse (in pixels), l¼ length of the
sample area (in pixels) and p¼ number of pixels per micron.
Synapse number for every condition was then normalized to control conditions
(EGFP transfected, or untreated condition). The normalized synapse number of
every image was averaged and the mean of the average synapse number across all
experiments was calculated for each condition. Pooled data from all images for
every condition was plotted with the standard error of the mean.
Somatic protein expression quantitation. To assess the somatic expression
level of speciﬁc proteins (for example, TRPV1, NGF and BDNF), the average
ﬂuorescence intensity in regions placed around somas was measured using ImageJ
or MetaMorph software. For quantitation of TRPV1 expression, the signal in
surrounding non-expressing TRPV1 neurons was set to zero, and any signal
remaining in WT (or TRPV1 knockout) neurons was calculated relative to zero.
The average soma ﬂuorescence intensity across all experiments was calculated for
each condition. Pooled data from all images for every condition were plotted with
the standard error of the mean.
Calcium imaging. To test if capsaicin activates hippocampal neurons in vitro
we used the Fluo-4 (Invitrogen) calcium indicator at a concentration of 1:1,000
added to DIV 13–14 mouse hippocampal neurons. After 10–20min of incubation,
coverslips were placed on a ﬁeld stimulation imaging chamber (Warner
Instruments) in 100–150 ml of base solution (140mM NaCl, 5mM KCl, 2mM
CaCl2, 2mM MgCl2, 5.5mM glucose, 20mM Hepes; pH¼ 7). For experiments in
which blockade of TRPV1 was tested, the base solution contained 10 mM APV,
10 mM CNQX and 1 mM TTX, with or without 1 mM SB-366791. The stimulation
chamber was connected to a biphasic stimulator and positioned on a Zeiss
AxioObserver A1 epiﬂuorescence microscope (Carl Zeiss) with a DG-4 wavelength
switcher (Sutter Instruments). A 40 /1.4 air Plan-Apochromat objective and a
488 nm wavelength ﬁlter was used to detect Fluo-4 ﬂuorescence (excitation–
emission: 494–516 nm). Three-minute time series of 1 frame per second were
acquired with an exposure time p200ms using an Evolve Camera (Photometrics)
controlled by MetaMorph software (Molecular Devices). After 1min baseline
recording, 30 pulses of 10 V at 40Hz and 1ms duration were delivered by ﬁeld
stimulation. Following ﬁeld stimulation, a ﬁnal concentration of 1 mM capsaicin, or
5 mM nicotine followed by 1 mM capsaicin (or corresponding volume of DMSO)
was added by pipette and samples were imaged for an additional minute.
For analysis of Ca2þ responses, somas of neurons responding to ﬁeld
stimulation were selected with the region tool in MetaMorph. Background
(the average intensity of ﬁve regions without visible neuronal processes or cell
bodies) was subtracted and the average intensity in cell somas throughout the time
course was determined using Metamorph and further analysed using a custom
written script in Matlab. Frames were clipped from individual traces such that time
of ﬁeld stimulation and time of addition of capsaicin or DMSO in each trace was
aligned with respect to each other. Fluorescence averaged over the ﬁrst 40 frames
was taken as baseline (F0). The DF/F0 traces were calculated over time (t). Cells that
had o 20% increase upon ﬁeld stimulation were excluded from analysis for
comparison of WT and TRPV1 knockout calcium responses. Cells that showed4
10% increase in Fluo-4 ﬂuorescence upon capsaicin or nicotine addition, were
considered responsive.
RNA isolation and RT–PCR. To detect expression of TRPV1 and its isoforms,
RNA was isolated from hippocampus and dorsal root ganglia (DRG) from
2- to 3-month-old WT (B6/J) and TRPV1 KO mice of both sexes. Animals were
killed with CO2 and hippocampi and DRG were dissected and isolated in sterile
1 PBS in DNase/RNase free Eppendorf tubes (ThermoFisher), snap-frozen with
liquid nitrogen and stored at  80 C. Tissue was dissected from each mouse using
separate tools to avoid contamination.
Hippocampi and DRG were homogenized with 500 ml or 250ml Trizol
(Sigma Aldrich), respectively, and incubated at RT for 5min. Subsequently, 100 ml
(hippocampus) or 50 ml (DRG) chloroform was added and mixed vigorously by
inverting the tube 15x and allowing solution to settle for 3min at RT. Samples were
then centrifuged for 15min at 4 C at 13,000 r.c.f. The upper aqueous supernatant
was transferred to a new tube, isopropanol was added (250 ml for hippocampus and
125 ml for DRG) and mixed by gentle inversion followed by -20 C incubation for
1 h. Samples were then centrifuged at 13,000 r.c.f. for 30min at 4 C. The
supernatant was discarded and the RNA pellet was washed with 1ml ice-cold
70% ethanol. After washing, a ﬁnal centrifugation step of 5min at 4 C RT
13,000 r.c.f. was performed, supernatant was discarded and the RNA pellet was
air-dried at RT. The RNA pellet was dissolved in DNase- and RNase-free water
(30 ml for hippocampus and 20 ml for DRG). Samples were treated with DNase I
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(Ambion) to eliminate any remaining chromosomal DNA. Purity and
concentration of RNA was determined using a spectrophotometer (NanoDrop
ND-1000) with ND-1000 v3.5.2 software (Peqlab Biotechnologie). Only isolated
RNA with an integrity value of more than 8 was used.
cDNA was synthesized using 2 mg (hippocampus) or 1 mg (DRG) of the
isolated RNA: RNA samples were diluted with DNase- and RNase-free water
to a ﬁnal volume of 11 ml and mixed with 9 ml of the cDNA synthesis reaction mix
(4ml 5 reaction buffer, 0.5 ml RNase inhibitor, 2 ml deoxynucleotides, 0.5 ml
reverse transcriptase, 2 ml random hexamer mix from Roche Applied Science) for a
ﬁnal volume of 20ml. RNA was reversed transcribed with the Transcriptor High
Fidelity cDNA synthesis kit (Roche Applied Science) under the following
conditions: 1 10min 25 C; 1 30min 55 C; and 1 5min 80 C, followed
by a hold at 4 C. A reverse transcription–PCR (RT–PCR) without reverse
transcriptase served as a negative control. Isolated RNA and negative controls
were stored at  20 C.
qPCR was performed on a light cycler 480 system (Roche Applied Science)
using the LC480 SYBR green Master mix (Roche Applied Science). 2 ml of the
synthesized cDNA library was used for qPCR with TRPV1 primers (see below) and
1:10 diluted cDNA was used for the reference control tubulin a-1B. All data
obtained was normalized to mRNA levels of tubulin alpha-1B. The qPCR reaction
mix contained 2 ml cDNA, 0.75ml 10mM forward and reverse primers, 7.5 ml LC480
2 Master mix, and 4 ml DNase- and RNase-free water. Cycling conditions were:
95 C 5min denaturation, repeated cycle of 95 C 10 s, 60 C 15 s, 72 C 10 s for
45 , one cycle of 95 C 15 s, 67 C 30 s, 95 C 15 s for the melting curve, followed
by 40 C 10 s, and 4 C hold.
Forward and reverse primers, respectively, were used for identiﬁcation of the
TRPV1 channel pore region; TRPV1 PR (50-cttgtttggattttccacagc-30 , 50-cacttg-
tgtggtggggact-30), the TRPV1 N-terminus; TRPV1 N-T (50-gagtgtgcctgcacctagc-30 ,
50-tcagattcatccgagtctaagc-30), the TRPV1 C-terminus; TRPV1 C-T (50-ggcatgt-
ccctaggacttca-30 , 50-agctcgcttcccacacac-30), the vanilloid receptor 50-splice variant;
VR.50sv (50-tgaccctcttggtggagaatgg-30 , 50-tgaggctagtccctggatgactg-30) and for
tubulin alpha-1B (50-aggagctggcaagcatgt-30 , 50-agctgctcaggctggaagag-30). All
primers were synthesized by and purchased from Sigma-Aldrich.
For VR.50 sv, the only published sequence to our knowledge was reported for rat
(Rattus norvegicus) tissue21 (GenBank accession number AF158248.2). We
designed primers to detect the same region in mouse, by aligning the TRPV1
genomic mouse sequence (GenBank accession number NC_000077.6) with the rat
TRPV1 genomic sequence (GenBank accession number NC_005109.4) using the
open source software ‘A plasmid editor’ v2.0.47 (Copyright 2003–2009 by M.
Wayne Davis) (ApE). We chose primers using the online tool ‘Universal Probe
Library Assay Design Center’ (Roche Diagnostics) by entering the complete NCBI
reference sequence (NM_001001445.2) for TRPV1, the sequences above for
VR.50 sv, or the speciﬁc exons we aimed to detect, that is, the amino and carboxyl
termini or pore region of TRPV1 or the unique VR.50 sv sequences.
Biochemistry and western blotting. For preparation of whole brain and
hippocampus homogenates, tissue was dissected from 2–4-month-old mice of both
sexes and collected in DNase- and RNase-free Eppendorf tubes and snap frozen in
liquid nitrogen. Tissue was homogenized in 9ml of 4 C homogenization buffer
(320mM sucrose and 4mM HEPES; pH 7.4, adjusted with NaOH; supplemented
with protease inhibitors; 1:1,000 dilution) using a glass-teﬂon homogenizer with
8–10 strokes at 900 r.p.m. Protein concentration was determined by BCA assay
(Novagen). Absorbance was measured at 562nm on a plate reader. Protein separation
was performed following the Scha¨gger protocol. Proteins were denaturated: samples
were mixed with Scha¨gger sample buffer (50mM Tris 4% SDS, 0.01% Serva Blue G,
12% glycerol; pH 6.8, adjusted with HCl; for reducing 2% mercaptoethanol) and
heated at 99 C for 10min. Equal amounts of protein were loaded into each lane and
proteins were separated by 10% SDS–polyac under constant current using a Bio-rad
electrophoresis power supply. Proteins were transferred from a polyacrylamide gel to
a nitrocellulose membrane at 100mA for 1 h.
For immunoblotting, membranes were incubated for 1 h at RT in blocking
buffer (5% lyophilized non-fat milk in 1X TBST). Primary antibody was then added
to the blocking buffer and the membrane was incubated O/N at 4 C in primary
antibody solution. The membrane was subsequently washed 3 with TBST and
then incubated for 1 h at RT with HRP-conjugated secondary antibodies in
blocking buffer. After washing 3with TBST, the custom-made chemiluminescent
substrate ECL consisting of 1ml of solution A (2.42 g Tris-HCl, 500mg luminol
sodium salt (Sigma-Aldrich) dissolved in 200ml ddH2O), 100ml of solution B
(11mg P-coumaric acid (Sigma-Aldrich) dissolved in 10ml DMSO) and 0.3 ml of
solution C (30–35% [v/v] of H2O2) was poured on the membrane and incubated
for at least 3min in darkness. For visualization, signal was captured using a LAS
reader (Fuji). The signal intensity was quantiﬁed using the open source software
Image J, and values were plotted in Excel (Microsoft).
mEPSC recordings in dissociated cultures. Whole-cell patch clamp recordings
from cultured rat hippocampal neurons (growing on glass coverslips) were
performed at RT at DIV12–14 in a custom-made recording chamber. Transfected
neurons were visualized with an upright Olympus BX51WI microscope (Olympus)
with 10 /0.3 water UMPlanFL N and 40 /0.3 LUMPlanFL N objectives and a
Lumen 200 Pro ﬂuorescent light source (Prior Scientiﬁc) and ﬁlters for GFP
detection to identify transfected neurons. The artiﬁcial cerebrospinal ﬂuid (ACSF)
extracellular solution contained (in mM) 136 NaCl, 2.5 KCl, 10 HEPES, 10 D-glu-
cose, 2 CaCl2 and 1.3 MgCl2; pH 7.4, adjusted with 10 M NaOH; 290–300 mOsm;
1 mM TTX (Tocris). ACSF was bubbled with carbogen (95% O2 and 5% CO2) to
achieve a pH of 7.2. For mEPSC recordings, the extracellular solution included
100 mM picrotoxin (Tocris); for mIPSC recordings, 10 mM CNQX and 10 mM APV
(Tocris) were added to the ACSF. The intracellular solution contained (in mM) 130
K-gluconate, 10 NaCl, 1 EGTA, 0.133 CaCl2, 2 MgCl2, 10 HEPES, 3.5 Na-ATP, 1
Na-GTP; pH¼ 7.3; 280 mOsm) for mEPSC detection and (in mM) 136 CsCl, 10
EGTA, 2 CaCl2, 0 MgCl2, 10 HEPES, 2 Mg-ATP, 0.3 Na-GTP; pH¼ 7.3, adjusted
with CsOH; 290–295 mOsm for mIPSC detection. Recordings were performed with
a HEKA EPC10 USB double patch clamp ampliﬁer coupled to Patchmaster
acquisition software (HEKA Electronics Inc.). Borosilicate glass 2–5 MO
micropipettes used for recording were pulled using a P-97 micropipette puller
(Sutter Instruments). Neurons were held in voltage-clamp mode at  60mV for
both mEPSC and mIPSC recordings. Data was ﬁltered using a low-pass Bessel ﬁlter
at 2.9 kHz and digitized at 5 kHz. Recorded traces were analysed using Mini
Analysis v6.0.3 software (Synaptosoft). The amplitude threshold for detection of
mEPSCs was approximately 3.5RMS noise. Only undisturbed traces of at least
1min. were considered for analysis. Average amplitude and frequency were plotted
with standard error of the mean.
Whole-cell recordings from OLM neurons in hippocampal slices. For recording
mEPSCs and capsaicin responses in OLM neurons from hippocampal slices,
P10-P24 mice of both sexes were anaesthetised with isoﬂuorane (Abbott,
Wiesbaden, Germany) and decapitated. The brain was dissected and placed in
ice-cold carbogen (95% CO2/5% O2) -bubbled NMDG cutting buffer (containing in
mM: 45 NMDG, 0.3 KCl, 0.4 KH2PO4, 0.5 MgCl2, 0.16 CaCl2, 20 choline
bicarbonate, 12.95 glucose). The cerebellum was removed and the brain glued to a
vibratome chamber ﬁlled with carbogen-bubbled ice-cold NMDG buffer. 300 mm
thick coronal hippocampal slices were cut using a Leica VT1200 vibratome
(Wetzlar, Germany) and a stainless steel blade (Feather). Slices were placed in a
submerged chamber containing carbogen-bubbled ACSF (in mM: 124 NaCl,
4.4 KCl, 1 NaH2PO4, 26.2 NaHCO3, 1.3 MgSO4, 2.5 CaCl2, 10 D-glucose), and
incubated for 30min at 32 C. Slices were then incubated for an additional 30min
at room temperature before recordings were performed. Slices were placed on an
upright Zeiss Examiner D1 microscope equipped with a  40 water-immersion
objective in a recording chamber ﬁlled with carbogen-bubbled perfusion of ACSF
containing 1 mM TTX and 0.1mM picrotoxin, and maintained at 32 C. Putative
OLM neurons were identiﬁed by morphology, using a  40 objective, as neurons
with a large somata in the stratum oriens of the CA1 region of the hippocampus.
These neurons were recorded from with patch pipettes with a resistance of
2.5–5MO prepared from glass capillaries (Harvard Apparatus, cat. no. 300060,
1.5mm OD, 0.86mm ID) using a P-97 puller (Sutter Inst, Novato, CA). The
intracellular pipette solution contained (in mM): 130 CsMeSO3, 2.67 CsCl, 10
Hepes, 1 EGTA, 4 Mg-ATP, 0.3 Na-GTP, 3 QX-314 Cl, 5 TEA-Cl, 15 Creatine-
phosphate disodium, 5 Creatinephosphokinase (mOsm¼ 303, pH¼ 7.44).
Whole-cell patch-clamp recordings were obtained using a NPI ELC-03XS patch
clamp ampliﬁer and digitized using an InstruTECH ITC-18 data acquisition
interface (HEKA Elektronik). A custom written procedure in Igor Pro 6.12A
(provided by Oliver Schluter, ENI Goettingen) was used to visualize and store
recorded data. Signals were low-pass ﬁltered using a Bessel ﬁlter at 3 kHz and
digitized at 10 kHz.
Whole-cell recordings were made for 2min in basal conditions without
capsaicin (12 sweeps of 10 s each), at a holding potential of  75mV to record
mEPSCs, after which the perfusion solution was switched to ACSF containing 1 mM
capsaicin. 50 additional sweeps (at 10 s intervals) were then recorded during
capsaicin treatment. The input and series resistance (Rs) were monitored every 10 s
during recording. Recordings where uncompensated Rs was4 30 MO or changed
by more than±20% during recording were not used for analysis. Input resistances
ranged from 100–400MO and did not change by more than±20% during the
course of the recording. Recorded baseline traces were analysed using Mini
Analysis v6.0.3 software (Synaptosoft) with an amplitude threshold for detection of
mEPSCs of approximately 3.5  RMS noise. Average mEPSC frequency and
amplitude were plotted with standard error of the mean. Cells in which the current
deviated signiﬁcantly from the standard deviation of the current recorded during a
2min baseline prior to capsaicin addition, were considered responsive to capsaicin.
Electrophysiological recording from hippocampal slices. Acute hippocampal
slices were prepared from 8–12 week old B6/J and TRPV1 KO adult male mice as
previously described. Animals were anaesthetised with isoﬂurane and decapitated.
The brain was removed from the skull and hippocampus was dissected. Transverse
400-mm-thick hippocampal slices were obtained using a tissue chopper (Stoelting).
Slices were collected in ice-cold ACSF (124mM NaCl, 4.9mM KCl, 1.2mM
KH2PO4, 2.0mM MgSO4, 2.0mM CaCl2, 24.6mM NaHCO3, 10.0mM D-glucose;
saturated with 95% O2 and 5% CO2; pH 7.4 and 305 mOsm).
Hippocampal slices were incubated for 3 h at 32 C and high oxygen tension
(by bubbling with 95% O2 and 5% CO2; 30 l h 1) in an interface chamber
containing 2ml ACSF. A constant ﬂow (0.76mlmin 1) of ACSF was perfused
continuously during the incubation. For recording and stimulation of ﬁeld
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excitatory post-synaptic potentials (fEPSPs), monopolar lacquer-coated stainless
steel electrodes (571000, A-M Systems) were positioned in the CA1 region. fEPSPs
were recorded using a differential AC ampliﬁer (Model 1700, A-M Systems) and a
power (1401) analogue to digital converter (Cambridge Electronic Design) and
tracked using the PWIN software (IFN Magdeburg). For each input, a
determination of the test stimulation strength was stipulated as the current
necessary to evoke a fEPSP of 40% of the maximal slope. 30min after incubation
with ACSF, the baseline recording was started with test stimuli consisting of
4 biphasic square pulses of constant current (0.2 Hz, 0.1ms per polarity) every
5min for at least 30min. Long-term potentiation (LTP) was induced with one
(1XTET) strong tetanization protocol consisting of 100 biphasic constant current
pulses at 100 Hz and 0.2ms per polarity. For LTP experiments testing the effect of
nicotine, 5 mM nicotine was applied 30min before LTP induction and throughout
the recording (1 h).
Statistical analysis. All statistical analysis was carried out using Prism 6 software
(GraphPad). All reported values in statistical analysis represent the mean of the
indicated data set, and error bars indicate s.e.m. For pairwise comparisons and
calculation of signiﬁcance, Student’s two-tailed type 2 t-tests with Welch’s
correction were performed, where *Po0.05, **Po0.01, and ***Po0.001. For
multiple comparisons, signiﬁcance was determined by one-way ANOVA with
Tukey’s post hoc test for multiple comparisons indicated by *Po0.05, **Po0.01,
***Po0.001, ****Po0.0001. For all statistical tests, data met the assumptions of the
test, for example, normal distribution, and variance of individual groups was
calculated and determined to be similar between groups that were statistically
compared.
Data availability. The data that support the ﬁndings of this study are available
within the article, its Supplementary Information ﬁles and from the corresponding
author upon reasonable request.
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